Dutaprostam Hart hylki 0,5/0,4 mg Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

dutaprostam hart hylki 0,5/0,4 mg

zentiva k.s.* - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg

Dutasteride Medical Valley Mjúkt hylki 0,5 mg Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

dutasteride medical valley mjúkt hylki 0,5 mg

medical valley invest ab - dutasteridum inn - mjúkt hylki - 0,5 mg

Dutasteride Sumar Pharma (Dutasteride ratiopharm) Mjúkt hylki 0,5 mg Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

dutasteride sumar pharma (dutasteride ratiopharm) mjúkt hylki 0,5 mg

alvogen ehf. - dutasteridum inn - mjúkt hylki - 0,5 mg

Nurofen Junior Appelsín (Nurofen Junior Appelsín) Mixtúra, dreifa 40 mg/ml Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

nurofen junior appelsín (nurofen junior appelsín) mixtúra, dreifa 40 mg/ml

reckitt benckiser healthcare (scandinavia) a/s - ibuprofenum inn - mixtúra, dreifa - 40 mg/ml

Nurofen Junior Jarðarber (Nurofen Junior Jarðarber) Mixtúra, dreifa 40 mg/ml Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

nurofen junior jarðarber (nurofen junior jarðarber) mixtúra, dreifa 40 mg/ml

reckitt benckiser healthcare (scandinavia) a/s - ibuprofenum inn - mixtúra, dreifa - 40 mg/ml

Travoprost/Timolol Medical Valley Augndropar, lausn 40 míkróg/ml + 5 mg/ml Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

travoprost/timolol medical valley augndropar, lausn 40 míkróg/ml + 5 mg/ml

medical valley invest ab - travoprostinum inn; timololum maleat - augndropar, lausn - 40 míkróg/ml + 5 mg/ml

Soltamcin Tafla með breyttan losunarhraða 6 mg/0,4 mg Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

soltamcin tafla með breyttan losunarhraða 6 mg/0,4 mg

williams & halls ehf. - solifenacinum súkkínat; tamsulosinum hýdróklóríð - tafla með breyttan losunarhraða - 6 mg/0,4 mg

Competact Eiropas Savienība - īslandiešu - EMA (European Medicines Agency)

competact

cheplapharm arzneimittel gmbh - lyfleysu, kvarta stutt og long-term - sykursýki, tegund 2 - lyf notuð við sykursýki - competact is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.

Edarbi Eiropas Savienība - īslandiešu - EMA (European Medicines Agency)

edarbi

takeda pharma a/s - azilsartan medoxomil - háþrýstingur - lyf sem hafa áhrif á renín-angíótensín kerfið - edarbi er ætlað til meðferðar við nauðsynlegum háþrýstingi hjá fullorðnum.

Eucreas Eiropas Savienība - īslandiešu - EMA (European Medicines Agency)

eucreas

novartis europharm limited - vildagliptin, kvarta stutt og long-term - sykursýki, tegund 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.